Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Meer behandelopties, flexibeler inzetbaar en uniformer gemonitord
mrt 2024 | Multipele Sclerose, Stamceltransplantatie, Vaccinatie